Your session is about to expire
β Back to Search
Home Visits for Pediatric HIV Adherence
N/A
Waitlist Available
Led By Elizabeth McFarland
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Taking at least 1 antiretroviral medication
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will test whether home visits to HIV infected children and youth, which identify previously unrecognized adherence barriers and provide support and education, will increase medication adherence and improve patient satisfaction.
Who is the study for?
This trial is for English-speaking children and youth with HIV who live in the Denver metro area and are on at least one antiretroviral medication. It aims to help those struggling with sticking to their medication schedule.Check my eligibility
What is being tested?
The study tests if home visits can uncover hidden barriers to taking HIV meds regularly, provide support, and improve relationships between patients and healthcare providers. Adherence will be measured before/after visits using questionnaires and pill counts or monitoring systems.See study design
What are the potential side effects?
Since this trial focuses on home visits rather than a new drug, there aren't direct side effects like you'd expect from medication. However, participants may experience increased stress or privacy concerns due to having health workers visit their homes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowSelect...
I am currently taking medication for HIV.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Elizabeth McFarlandPrincipal Investigator
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking medication for HIV.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the selection criteria for this research include adults, aged 20 and older?
"This trial is actively seeking individuals aged between infancy and 24 years old."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger